Media Highlights
Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs
April 15, 2024
Dr. Mikkael A. Sekeres is quoted in this article that discusses lawmakers’ rising national security concerns over a connection between a major Chinese firm and U.S. pharmaceutical interests. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
